Literature DB >> 2197151

Cystic fibrosis: a disease in electrolyte transport.

P M Quinton1.   

Abstract

Cystic fibrosis (CF) is a fatal genetic disease caused by abnormalities in fluid and electrolyte transport in exocrine epithelia. Both absorptive and secretory processes are affected by an underlying membrane defect in Cl- permeability. However, the impact of the defect on transport function is tissue specific. Net electrolyte absorption is decreased in the sweat duct, increased in airway epithelia, and not affected in intestine. The defect is expressed in secretion as a consistent failure in most, if not all, exocrine tissues, to beta-adrenergically stimulated and cAMP mediated secretory response. However, the secretory response to cholinergic and Ca2(+)-mediated stimulation is normal in the sweat gland, apparently normal in the airway, but absent in the intestine. The basic defect is not fatal in and of itself, and the imbalance between absorption and secretory functions may be of some selective advantage to heterozygotes in surviving complications of intestinal infections. The inherent defect in transport is probably the primary physiological cause of the ultimately fatal secondary infections in the lungs of CF homozygotes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197151     DOI: 10.1096/fasebj.4.10.2197151

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  100 in total

Review 1.  Role of epithelial HCO3⁻ transport in mucin secretion: lessons from cystic fibrosis.

Authors:  Paul M Quinton
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-06       Impact factor: 4.249

2.  The cystic fibrosis transmembrane conductance regulator chloride channel. Iodide block and permeation.

Authors:  J A Tabcharani; X B Chang; J R Riordan; J W Hanrahan
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

Review 3.  Cystic fibrosis. 6. Gastrointestinal and nutritional aspects.

Authors:  H Kopelman
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

4.  Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27.

Authors:  Miquéias Lopes-Pacheco; Clément Boinot; Inna Sabirzhanova; Marcelo M Morales; William B Guggino; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2015-09-02       Impact factor: 5.157

5.  Purification and characterization of the apical plasma membrane of the rat pancreatic acinar cell.

Authors:  E Paul; Y Hurtubise; D LeBel
Journal:  J Membr Biol       Date:  1992-04       Impact factor: 1.843

6.  Evidence for a cytosolic inhibitor of epithelial chloride channels.

Authors:  W Krick; J Disser; A Hazama; G Burckhardt; E Frömter
Journal:  Pflugers Arch       Date:  1991-06       Impact factor: 3.657

7.  Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.

Authors:  Jiunn-Tyng Yeh; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2018-12-02       Impact factor: 5.182

8.  Acidic Submucosal Gland pH and Elevated Protein Concentration Produce Abnormal Cystic Fibrosis Mucus.

Authors:  Yuliang Xie; Lin Lu; Xiao Xiao Tang; Thomas O Moninger; Tony Jun Huang; David A Stoltz; Michael J Welsh
Journal:  Dev Cell       Date:  2020-07-29       Impact factor: 12.270

9.  Antisense oligodeoxynucleotide to the cystic fibrosis transmembrane conductance regulator inhibits cyclic AMP-activated but not calcium-activated cell volume reduction in a human pancreatic duct cell line.

Authors:  H Kopelman; C Gauthier; M Bornstein
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Ketoconazole activates Cl- conductance and blocks Cl- and fluid absorption by cultured cystic fibrosis (CFPAC-1) cells.

Authors:  U Kersting; D Kersting; K R Spring
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.